Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RUVWI
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
B2M-duocarmycin ADC
|
|||||
| Synonyms |
B2M duocarmycin ADC
Click to Show/Hide
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Senescence [ICD11:MG2A]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2.02
|
|||||
| Antibody Name |
LS-B2200
|
Antibody Info | ||||
| Antigen Name |
Beta-2-microglobulin (B2M)
|
Antigen Info | ||||
| Payload Name |
Duocarmycin A
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Bis-Tolylsulfonyl-Propanoyl-Benzamide-Glu-NH-PEG(24u)-OMe-Val-Cit-PAB
|
Linker Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.